242 related articles for article (PubMed ID: 33964910)
1. Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
Weiss DJ; Segal K; Casaburi R; Hayes J; Tashkin D
Respir Res; 2021 May; 22(1):142. PubMed ID: 33964910
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
Weiss DJ; Casaburi R; Flannery R; LeRoux-Williams M; Tashkin DP
Chest; 2013 Jun; 143(6):1590-1598. PubMed ID: 23172272
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
6. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
7. Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.
de Oliveira HG; Cruz FF; Antunes MA; de Macedo Neto AV; Oliveira GA; Svartman FM; Borgonovo T; Rebelatto CL; Weiss DJ; Brofman PR; Morales MM; Lapa E Silva JR; Rocco PR
Stem Cells Transl Med; 2017 Mar; 6(3):962-969. PubMed ID: 28186686
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
9. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
10. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
11. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial.
Kikuchi H; Shiozawa N; Takata S; Ashida K; Mitsunobu F
Int J Chron Obstruct Pulmon Dis; 2014; 9():9-15. PubMed ID: 24363555
[TBL] [Abstract][Full Text] [Related]
13. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
15. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
Aarli BB; Calverley PM; Jensen RL; Dellacà R; Eagan TM; Bakke PS; Hardie JA
Int J Chron Obstruct Pulmon Dis; 2017; 12():2179-2188. PubMed ID: 28794622
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
17. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
[TBL] [Abstract][Full Text] [Related]
18. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
[TBL] [Abstract][Full Text] [Related]
19. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.
Beeh KM; Singh D; Di Scala L; Drollmann A
Int J Chron Obstruct Pulmon Dis; 2012; 7():503-13. PubMed ID: 22973092
[TBL] [Abstract][Full Text] [Related]
20. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.
Kerti M; Balogh Z; Kelemen K; Varga JT
Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
